Oculis Holding AG (OCS) Beginning Cash Balance (2023 - 2026)

Oculis Holding AG's (OCS) quarterly Beginning Cash Balance came in at $103.9 million in Q1 2026, up 237.0% year-on-year from $30.8 million in Q1 2025, and up 237.0% quarter-over-quarter from $30.8 million in Q1 2025.

Oculis Holding AG (OCS) Beginning Cash Balance (2023 - 2026) Analysis & Trends

Oculis Holding AG's Beginning Cash Balance history runs 4 years deep, the most recent figure standing at $103.9 million for Q1 2026.

  • On a quarterly basis, Beginning Cash Balance rose 237.0% year-over-year to $103.9 million in Q1 2026; TTM through Mar 2026 was $103.9 million, a 237.0% increase from a year earlier, with the FY2025 full-year figure at $33.4 million, down 23.29% from the prior year.
  • Beginning Cash Balance advanced to $103.9 million in Q1 2026 per OCS's latest filing, from $30.8 million in the prior quarter.
  • Across five years, Beginning Cash Balance topped out at $103.9 million in Q1 2026 and bottomed at $21.4 million in Q1 2023.
  • The 4-year median for Beginning Cash Balance is $37.4 million (2024), against an average of $50.0 million.
  • Across the five-year window, Beginning Cash Balance declined 29.82% in 2025 and jumped 237.0% in 2026, its largest moves.
  • Year by year, Beginning Cash Balance stood at $21.4 million in 2023, then soared by 105.27% to $43.9 million in 2024, then declined by 29.82% to $30.8 million in 2025, then jumped by 237.0% to $103.9 million in 2026.
  • Per Business Quant, the three latest OCS Beginning Cash Balance figures stand at $103.9 million (Q1 2026), $30.8 million (Q1 2025), and $43.9 million (Q1 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 103.86 Mn
Mar 31, 2026 103.86 Mn
Mar 31, 2025 30.82 Mn
Mar 31, 2025 30.82 Mn
Mar 31, 2024 43.91 Mn
Mar 31, 2024 43.91 Mn
Mar 31, 2023 21.39 Mn
Mar 31, 2023 21.39 Mn